title: Administration of antiprogestin J956 for contraception in bears: a pharmacological study.
abstract: Effective and reversible control of reproduction in bears is highly desirable for conservation and management programs in zoos to establish genetically variable ex-situ populations of bears within the constraints of limited space in captivity. The reproductive physiology of bears is characterized by two main traits--seasonality and delayed implantation, which is progesterone dependent. This offers the opportunity to interrupt early pregnancy by short-term administration of antiprogestins. The aim of the present study was to investigate the pharmacological characteristics of antiprogestin J956 to establish an efficient contraceptive protocol for administration of J956 in captive bears. The J956 binds to the uterine progesterone receptor of bears (n = 2) with almost the same relative binding affinity (1.25) as progesterone. The blood serum level of J956 after oral (on four consecutive days) and single parenteral administration was determined by a modified progestin receptor assay. The relative bioavailability of J956 after oral administration was approximately 10% of the parenteral administration. The estimated half-life was 12 to 16 hours after oral administration. Parenteral treatment of J956 (10 mg/kg body mass) led to sustain plasma concentrations (6.4 +/- 1.3 ng/mL) in one black bear and in five brown bears. The plasma level lasted for almost 2 months. Oral and low dosage parenteral (1 mg/kg body mass) administration of J956 had no effect on ongoing pregnancies in bears. Whereas single parenteral administration with higher dosages of J956 (7.5 to 10 mg/kg body mass) efficiently prevented implantation of early embryos in eight female captive bears.
authors.affiliation: Institute for Zoo Biology and Wildlife Research, Berlin, Germany. jewgenow@izw-berlin.de
authors.forename: K
authors.initials: K
authors.lastname: Jewgenow
authors.forename: M
authors.initials: M
authors.lastname: Quest
authors.forename: W
authors.initials: W
authors.lastname: Elger
authors.forename: T B
authors.initials: TB
authors.lastname: Hildebrandt
authors.forename: H H
authors.initials: HH
authors.lastname: Meyer
authors.forename: G
authors.initials: G
authors.lastname: Strauss
authors.forename: F
authors.initials: F
authors.lastname: Göritz
mesh_terms: D000284:Administration, Oral; D000818:Animals; D001682:Biological Availability; D003271:Contraceptive Agents, Female / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D005260:Female; D007273:Injections, Intramuscular / Q000662:veterinary; D011247:Pregnancy; D011372:Progestins / Q000037:antagonists & inhibitors*; D011980:Receptors, Progesterone / Q000037:antagonists & inhibitors / Q000378:metabolism; D001503:Ursidae / Q000097:blood / Q000378:metabolism / Q000502:physiology*
chemical_list: D003271:Contraceptive Agents, Female; D011372:Progestins; D011980:Receptors, Progesterone